The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 105-110

  Tian, Jing ^a   Ma, Yan ^a   Li, Jing ^a   Cen, Han ^a   Wang, De Guang ^a   Feng, Chen Chen ^a   Li, Ruo Jie ^a   Leng, Rui Xue ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Sex; Single nucleotide polymorphism; Systemic lupus erythematosus; TLR7

Indexed keywords

TOLL LIKE RECEPTOR 7;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TLR 7 GENE;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; TOLL-LIKE RECEPTOR 7; YOUNG ADULT;

EID: 84861607208     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.865     Document Type: Article

References (53)

1. Rahman A and Isenberg DA: Systemic lupus erythematosus. N Engl J Med 358: 929-939, 2008. (Pubitemid 351397092)
2. Davidson A and Diamond B: Autoimmune diseases. N Engl J Med 345: 340-350, 2001.
3. Imler JL and Hoffmann JA: Toll receptors in innate immunity. Trends Cell Biol 11: 304-311, 2001.
4. Jarrossay D, Napolitani G, Colonna M, Sallusto F and Lanzavecchia A: Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31: 3388-3393, 2001. (Pubitemid 33100532)
5. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F and Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869, 2001. (Pubitemid 32983021)
6. Dorner M, Brandt S, Tinguely M, et al: Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology 128: 573-579, 2009.
7. Beutler B, Jiang Z, Georgel P, et al: Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24: 353-389, 2006.
8. Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004. (Pubitemid 38931765)
9. Roelofs MF, Abdollahi-Roodsaz S, Joosten LA, van den Berg WB and Radstake TR: The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 58: 338-348, 2008. (Pubitemid 351294868)
10. Kopp EB and Medzhitov R: The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11: 13-18, 1999. (Pubitemid 29082330)
11. Akira S, Takeda K and Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680, 2001. (Pubitemid 32747155)
12. Chow JC, Young DW, Golenbock DT, Christ WJ and Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274: 10689-10692, 1999.
13. Gilliet M, Cao W and Liu YJ: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606, 2008.
14. Santiago-Raber ML, Dunand-Sauthier I, Wu T, et al: Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 34: 339-348, 2010.
15. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB and Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672, 2006. (Pubitemid 43902669)
16. Fairhurst AM, Hwang SH, Wang A, et al: Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur J Immunol 38: 1971-1978, 2008.
17. Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K and Shlomchik MJ: TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184: 1840-1848, 2010.
18. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA and Shlomchik MJ: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428, 2006. (Pubitemid 44354217)
19. Barrat FJ, Meeker T, Chan JH, Guiducci C and Coffman RL: Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37: 3582-3586, 2007.
20. Tabeta K, Hoebe K, Janssen EM, et al: The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7: 156-164, 2006. (Pubitemid 43135881)
21. Santiago-Raber ML, Kikuchi S, Borel P, Uematsu S, Akira S, Kotzin BL and Izui S: Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 181: 1556-1562, 2008.
22. Subramanian S, Tus K, Li QZ, et al: A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103: 9970-9975, 2006. (Pubitemid 43993607)
23. Komatsuda A, Wakui H, Iwamoto K, et al: Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 152: 482-487, 2008. (Pubitemid 351661498)
24. García-Ortiz H, Velázquez-Cruz R, Espinosa-Rosales F, Jiménez-Morales S, Baca V and Orozco L: Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis 69: 1861-1865, 2010.
25. Dugernier T, Huaux JP, Coche E, Nagant C and Deuxchaisnes D: Klinefelter's syndrome and lupus erythematosus: report of a case. Clin Rheumatol 6: 84-87, 1987.
26. Sasaki N, Yamauchi K, Sato R, Masuda T, Sawai T and Inoue H: Klinefelter's syndrome associated with systemic lupus erythematosus and autoimmune hepatitis. Mod Rheumatol 16: 305-308, 2006. (Pubitemid 44575257)
27. Gilliland WR and Stashower ME: Klinefelter's syndrome and systemic lupus erythematosus. Clin Exp Rheumatol 18: 107-109, 2000. (Pubitemid 30102056)
28. Holland C: 47, Xxx in an adolescent with premature ovarian failure and autoimmune disease. J Pediatr Adolesc Gynecol 13: 93, 2000.
29. Balestrazzi P, Ferraccioli GF, Ambanelli U and Giovannelli G: Juvenile rheumatoid arthritis in Turner's syndrome. Clin Exp Rheumatol 4: 61-62, 1986. (Pubitemid 16166426)
30. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.
31. Faul F, Erdfelder E, Buchner A and Lang AG: Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41: 1149-1160, 2009.
32. Scofield RH, Bruner GR, Namjou B, et al: Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58: 2511-2517, 2008.
33. Smith-Bouvier DL, Divekar AA, Sasidhar M, et al: A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205: 1099-1108, 2008. (Pubitemid 351679685)
34. Chagnon P, Schneider R, Hébert J, et al: Identification and characterization of an Xp22.33; Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 54: 1270-1278, 2006. (Pubitemid 43672939)
35. Deane JA, Pisitkun P, Barrett RS, et al: Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810, 2007. (Pubitemid 350102256)
36. Sánchez E, Callejas-Rubio JL, Sabio JM, et al: Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. Clin Exp Rheumatol 27: 267-271, 2009.
37. Dos Santos BP, Valverde JV, Rohr P, Monticielo OA, Brenol JC, Xavier RM and Chies JA: TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from Southern Brazil. Lupus: Nov 7, 2011 (Epub ahead of print).
38. Shen N, Fu Q, Deng Y, et al: Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA 107: 15838-15843, 2010.
39. Kawasaki A, Furukawa H, Kondo Y, et al: TLR7 single- nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther 13: R41, 2011.
40. Pan HF, Li WX, Yuan H, et al: Susceptibility to systemic lupus erythematosus may be related to gene dosage effect of the X chromosome. Med Hypotheses 72: 104-105, 2009.
41. Soni SS, Gowrishankar S, Adikey GK and Raman A: Sex-based differences in lupus nephritis: a study of 235 Indian patients. J Nephrol 21: 570-575, 2008.
42. Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR and Harley JB: Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 12: 99-106, 2003. (Pubitemid 36240842)
43. Andrade RM, Alarcón GS, Fernández M, Apte M, Vilá LM, Reveille JD; LUMINA Study Group: Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 56: 622-630, 2007.
44. de Carvalho JF, do Nascimento AP, Testagrossa LA, Barros RT and Bonfá E: Male gender results in more severe lupus nephritis. Rheumatol Int 30: 1311-1315, 2010.
45. Santiaqo-Raber ML, Baudino L and Lzui S: Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun 33: 231-238, 2009.
46. Baudino L, Yoshinobu K, Morito N, Santiago-Raber ML and Izui S: Role of endogenous retroviruses in murine SLE. Autoimmun Rev 10: 27-34, 2010.
47. Baudino L, Yoshinobu K, Dunand-Sauthier I, Evans LH and Izui S: TLR-mediated up- regulation of serum retroviral gp70 is controlled by the Sgp loci of lupus-prone mice. J Autoimmun 35: 153-159, 2010.
48. Yoshiki T, Mellors RC, Strand M and August JT: The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 140: 1011-1027, 1974.
49. Izui S, McConahey PJ, Theofilopoulos AN and Dixon FJ: Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med 149: 1099-1116, 1979. (Pubitemid 9181917)
50. Izui S, McConahey PJ, Clark JP, Hang LM, Hara I and Dixon FJ: Retroviral gp70 immune complexes in NZB X NZW F2 mice with murine lupus nephritis. J Exp Med 154: 517-528, 1981. (Pubitemid 11044181)
51. Maruyama N, Furukawa F, Nakai Y, et al: Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease. J Immunol 130: 740-746, 1983. (Pubitemid 13186298)
52. Vyse TJ, Drake CG, Rozzo SJ, Roper E, Izui S and Kotzin BL: Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J Clin Invest 98: 1762-1772, 1996. (Pubitemid 26359192)
53. Haywood ME, Vyse TJ, McDermott A, et al: Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone PXSB mice. J Immunol 167: 1728-1733, 2001. (Pubitemid 32703176)